The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tango Therapeutics Inc shares valued at $37,800 were purchased by Rothenberg Mace on Nov 18 ’24. At $3.78 per share, Rothenberg Mace acquired 10,000 shares. The insider’s holdings grew to 31,250 shares worth approximately $0.13 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Rothenberg Mace purchased 10,000 shares, netting a total of over 36,200 in proceeds. Following the buying of shares at $3.62 each, the insider now holds 21,250 shares.
Before that, EcoR1 Capital, LLC had sold 1,494,558 shares from its account. In a trade valued at $4,896,023, the 10% Owner traded Tango Therapeutics Inc shares for $3.28 each. Upon closing the transaction, the insider’s holdings decreased to 1,494,558 shares, worth approximately $48.29 million.
As published in their initiating research note from Jefferies on July 17, 2024, Tango Therapeutics Inc [TNGX] has been a Buy and the price target has been revised to $19. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early April. As of February 12, 2024, Piper Sandler has initiated its “an Overweight” rating for TNGX. Earlier on December 08, 2023, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for TNGX stock.
Analyzing TNGX Stock Performance
Over the course of the year, Tango Therapeutics Inc shares have dropped approximately -58.79%. Shares of the company reached a 52-week high of $13.01 on 01/25/24 and a 52-week low of $2.70 on 11/11/24. A 50-day SMA is recorded $5.76, while a 200-day SMA reached $8.19. Nevertheless, trading volume fell to 1.03 million shares from 1.26 million shares the previous day.
Support And Resistance Levels for Tango Therapeutics Inc (TNGX)
According to the 24-hour chart, there is a support level at 3.89, which, if violated, would cause prices to drop to 3.70. In the upper region, resistance lies at 4.19. The next price resistance is at 4.30. RSI (Relative Strength Index) is 42.72 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.21, which suggests the price will decrease in the coming days. Percent R is at 9.21%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Tango Therapeutics Inc (TNGX)?
On October 20, 2022, H.C. Wainwright assigned a price target of “a Buy” to the stock and upgraded coverage with a $10.
